The United States Food and Drug Administration FDA Puts Out Warning for Ranitidine Users
In early April 2020, the U.S. Food and Drug Administration FDA warned that the over the counter heartburn medication Zantac ranitidine was unsafe. The FDA said this because all ranitidine products contain unacceptable levels of NDMA (N Nitrosodimethylamine NDMA).
When N Nitrosodimethylamine NDMA breaks down, ranitidine drugs can lead to cancer or probable human carcinogen if the levels of NDMA build up too much so you should talk to a health care professional about prescriptions and the FDA recall.